Clinical Trial

A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated September 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
Aim of this study is to predict the prognostic values of Neutrophil/ Lymphocyte ratio and Lactate/Albumin ratio in the outcome of patients with sepsis and septic shock with lower respiratory tract infection, also to compare between them regarding sensitivity and specificity.
Trial Details
NCT Number NCT07089524
Lead Sponsor Ain Shams University
Conditions Sepsis
Enrollment 160 participants
Start Date 2024-09-11
Primary Completion 2025-09-11 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28